MedTrace Logo

Breath Gas Analysis for the Diagnosis of Breast Cancer

NCT01105468 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 202

Last updated 2013-01-14

No results posted yet for this study

Summary

The volatile content of the exhaled breath gas of mamma carcinoma patients will be chemically analyzed by proton-transfer-reaction time of flight mass spectrometry.

The goal of the study is to determine typical breath gas components that allow to distinguish patients with mamma carcinoma from women without carcinoma. Further, the investigators will test whether these breath gas markers can be used as tumor markers, which change in a typical manner during the progress of the disease. Finally the data will be investigated for the presence of marker components, that identify patients who will develop metastasis.

Conditions

  • Mamma Carcinoma

Interventions

DEVICE

Breath Collecting Unit

Collect two breath gas samples per patient on one day before surgery

DEVICE

Breath Collecting Unit

Collect two or more breath gas samples on different days during adjuvant or neo-adjuvant therapy.

Sponsors & Collaborators

  • Medical University Innsbruck

    collaborator OTHER

  • Ionimed Analytik GmbH

    lead INDUSTRY

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2013-04-30
Completion
2017-04-30

Countries

  • Austria

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01105468 on ClinicalTrials.gov